Types of Leukaemia — ALL, AML, CML, CLL Explained

The four main types of leukaemia are ALL (Acute Lymphoblastic Leukaemia), AML (Acute Myeloid Leukaemia), CML (Chronic Myeloid Leukaemia) and CLL (Chronic Lymphocytic Leukaemia). Doctors group them by two things. First, how fast the cancer grows - acute means fast, chronic means slow. Second, which blood cell line is affected - lymphoid or myeloid. So ALL is fast and lymphoid, AML is fast and myeloid, CML is slow and myeloid, and CLL is slow and lymphoid. Knowing your exact type is important because each one behaves differently and needs a different treatment plan. At CION, your type is confirmed with careful testing and reviewed by a team before any plan is made.

The main difference is speed. Acute leukaemia grows quickly. The bone marrow makes many very immature cells in a short time, so symptoms appear fast and treatment usually starts soon after diagnosis. ALL and AML are the acute types. Chronic leukaemia grows slowly, often over months or years. The cells are more mature, and some people have few or no symptoms early on. CML and CLL are the chronic types. Because chronic leukaemia is slow, doctors sometimes watch it closely before starting treatment. This is called active monitoring. Your doctor will explain which pattern applies to you and what it means for the timing of your care.

ALL, or Acute Lymphoblastic Leukaemia, is the most common cancer in children. It is a fast-growing leukaemia that affects lymphoid cells. While ALL is most often seen in children, adults can develop it too. The good news is that treatment for childhood ALL has improved a great deal over the years, and many children respond very well. AML can also occur in children, but it is less common than ALL in this age group. Every child's case is different, so an exact diagnosis matters. At CION, we explain a child's reports gently and clearly to families, and we make decisions through a team, always for healing rather than billing.

The difference is which type of blood cell becomes cancerous. Your bone marrow makes two main cell lines. The lymphoid line produces lymphocytes, a kind of white blood cell that fights infection. The myeloid line produces red blood cells, platelets and other white blood cells. Lymphoid leukaemias affect lymphocytes - these are ALL and CLL. Myeloid leukaemias affect myeloid cells - these are AML and CML. This distinction matters because the treatments differ. Special lab tests look at the cells under a microscope and check for genetic markers to confirm the line. We explain these results to you in plain language during your 45-minute consultation, so nothing feels like a mystery.

CML, or Chronic Myeloid Leukaemia, is a slow-growing myeloid leukaemia linked to a gene change called the Philadelphia chromosome. We cannot promise a cure for any cancer, and we will never make that claim. However, treatment for CML has improved greatly. Many people now take a daily targeted tablet that keeps the disease well controlled, allowing them to live full and active lives for many years. Doctors monitor blood markers regularly to see how well the treatment is working. The right plan depends on the disease phase, your age and your overall health. At CION, your CML care is guided by a team, with honest discussion of your outlook and fully transparent costs.

Sometimes, yes - and this can be the right choice. CLL, or Chronic Lymphocytic Leukaemia, is a slow-growing leukaemia most common in older adults. Many people have no symptoms early on, and it is often found by chance on a routine blood test. When the disease is not causing problems, doctors may choose active monitoring, sometimes called watch and wait. This means regular check-ups and blood tests instead of immediate treatment. Treatment begins only when there are clear signs it is needed. This careful approach avoids the side effects of treatment when it is not yet helpful. It reflects our belief in decisions for healing, not billing. Your doctor will explain whether monitoring or treatment is right for you.

Diagnosing the exact type of leukaemia takes a few steps. It usually starts with a complete blood count, a simple blood test that shows the numbers and look of your blood cells. If leukaemia is suspected, the next step is often a bone marrow test, where a small sample is taken from inside the bone. Special lab tests then examine the cells closely. These include immunophenotyping (flow cytometry), cytogenetic tests and molecular tests that look for specific gene changes. Together, these results confirm whether the leukaemia is acute or chronic, and lymphoid or myeloid. At CION, we order only the tests that are truly needed, and we explain each result to you. We never run unnecessary tests.

There is no single answer, because seriousness depends on many things - the exact type, the sub-type, your age, your overall health and how the disease responds to treatment. In general, acute leukaemias like ALL and AML grow fast and usually need prompt treatment. Chronic leukaemias like CML and CLL grow slowly and are often well controlled for many years. But this is a broad rule, not a fixed one. Some acute leukaemias respond very well, especially in children. Some chronic cases need more active care. We will never give you a frightening label or a false promise. Instead, your CION team will explain your individual situation honestly, so you understand what your specific diagnosis means.

Symptoms can overlap between the types, and some people - especially with chronic leukaemia - have no symptoms at first. Common signs include ongoing tiredness or weakness, frequent infections, easy bruising or bleeding, and unexplained fever or night sweats. Some people notice swollen lymph nodes, bone or joint pain, or weight loss. These symptoms can also come from many harmless causes, so they do not always mean leukaemia. The only way to know is through proper testing. If you have worrying symptoms, please do not panic, but do see a doctor for a check-up. At CION, we listen carefully, order only necessary tests, and explain what your results mean without alarming language.

Knowing the exact type and sub-type guides every treatment decision. ALL, AML, CML and CLL each behave differently and respond to different treatments. For example, CML is often controlled with daily targeted tablets, while acute types may need a more intensive approach. Genetic markers within a type can further change the plan and the expected outlook. This is why a precise diagnosis comes before any treatment. Getting it right protects you from treatment that does not fit your disease. At CION, every patient's case is reviewed by a tumor board, so the plan is built by a team rather than one person. We make decisions for your healing, keep costs transparent, and never order tests you do not need.